Inventor
SEAMON KYLE
US20 patents
Patents
20 patentsUS10767169B1Sep 8, 2020
Nucleic acid-guided nucleases
INSCRIPTA INC43 citations98
US10745678B1Aug 18, 2020
Nucleic acid-guided nucleases
INSCRIPTA INC51 citations98
US10724021B1Jul 28, 2020
Nucleic acid-guided nucleases
INSCRIPTA INC51 citations98
US10704033B1Jul 7, 2020
Nucleic acid-guided nucleases
INSCRIPTA INC52 citations98
US10883095B1Jan 5, 2021
Mad nucleases
INSCRIPTA INC11 citations94
US10655114B1May 19, 2020
Engineered enzymes
INSCRIPTA INC11 citations94
US10640754B1May 5, 2020
Engineered enzymes
INSCRIPTA INC12 citations94
US10604746B1Mar 31, 2020
Engineered enzymes
INSCRIPTA INC16 citations94
US11085030B2Aug 10, 2021
MAD nucleases
INSCRIPTA INC3 citations84
US11053485B2Jul 6, 2021
MAD nucleases
INSCRIPTA INC5 citations84
US11008557B1May 18, 2021
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
INSCRIPTA INC5 citations84
US10876102B2Dec 29, 2020
Engineered enzymes
INSCRIPTA INC9 citations84
US10870841B1Dec 22, 2020
Nucleic acid-guided nucleases
INSCRIPTA INC5 citations84
US11345903B2May 31, 2022
Engineered enzymes
INSCRIPTA INC1 citations73
US11193115B2Dec 7, 2021
Mad nucleases
INSCRIPTA INC2 citations73
US11174471B2Nov 16, 2021
Mad nucleases
INSCRIPTA INC1 citations73
US11359187B1Jun 14, 2022
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
INSCRIPTA INC0 citations62
US11286471B1Mar 29, 2022
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
INSCRIPTA INC0 citations62
US11198857B2Dec 14, 2021
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
INSCRIPTA INC0 citations62
US11104890B1Aug 31, 2021
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
INSCRIPTA INC0 citations62